Registration, quality assurance and the shape of a medicines contract
A medicines tender is decided on quality assurance before it is decided on price. Bidders must show that the product is authorised or registered for use in the destination market, that it is manufactured at a site holding current good manufacturing practice certification, and -- for many donor-funded and essential medicines programs -- that the product or its manufacturer appears on a recognised prequalification list. These are documentary conditions of admissibility assessed against the specific product and manufacturing site offered, and a change of site after award is a contractual event, not an administrative one.
Products are specified by international non-proprietary name, strength and dosage form so that generics compete openly, with pharmacopoeial standards cited for quality. Delivery conditions carry as much weight as the product: a minimum proportion of shelf life remaining on arrival, batch certificates of analysis, tamper-evident and correctly labelled packaging in the required language, and unbroken cold chain with temperature monitoring for products that need it. A consignment that arrives with too little shelf life left is routinely rejected at the buyer's cost to the supplier.
The commercial structure is usually a framework at agreed unit prices with call-offs against forecast rather than firm volume, because demand depends on disease patterns and program funding. That places emphasis on lead times, on the supplier's obligation to hold or replenish stock, and on what happens in a shortage -- allocation, substitution and notification terms are increasingly explicit. Recall capability is tested rather than assumed: buyers ask how quickly a batch can be traced and withdrawn from every facility it reached.
This section describes how this category is bought generally, across the public buyers that publish it. The figures elsewhere on this page are measured for this market alone.
Who buys pharmaceuticals in Cyprus?
GlobalGov holds 49 pharmaceuticals records from 13 distinct buying organizations in Cyprus. The most frequent publishers are International buyer (9 records); International buyer (8 records); International buyer (4 records); International buyer (4 records); International buyer (3 records); International buyer (3 records). Between them the 6 largest account for 63% of everything published, so buying here is concentrated in a few authorities.
| Buying organization | Records | Share |
|---|---|---|
| International buyer | 9 | 18% |
| International buyer | 8 | 16% |
| International buyer | 4 | 8.2% |
| International buyer | 4 | 8.2% |
| International buyer | 3 | 6.1% |
| International buyer | 3 | 6.1% |
What are pharmaceuticals contracts worth in Cyprus?
37 of the 49 records publish a contract value. The median is $630,234 and the largest single published value is $17.6M. By size, 2 under $100k, 23 between $100k and $1M, 9 between $1M and $10M, 3 above $10M. The remaining 12 publish no value at all, so every figure here describes the priced subset only, and values are as stated by the buyer rather than as finally awarded.
| Contract size | Records | Share of priced |
|---|---|---|
| under $100k | 2 | 5.4% |
| between $100k and $1M | 23 | 62% |
| between $1M and $10M | 9 | 24% |
| above $10M | 3 | 8.1% |
How long do bidders get to respond to pharmaceuticals tenders in Cyprus?
Across the 19 Cyprus pharmaceuticals notices that publish both a publication date and a closing date, the median response window is 35 days. A quarter of them allowed 32 days or fewer and a quarter stayed open for more than 42. Short turnarounds are the exception rather than the rule here: only 1 (5.3%) closed within a fortnight of being published.
How often are pharmaceuticals tenders published in Cyprus?
Cyprus published 18 notices in this category in the last twelve months. Over the last three years there were 34, spread across 28 separate months of activity since 11 June 2021. May is historically the busiest month. The most recent was published 6 November 2026.
How does Cyprus compare with other pharmaceuticals markets?
Among the 45 countries where GlobalGov holds a comparable pharmaceuticals market, Cyprus ranks 42nd by number of records. The largest is Poland (9,417 records against 49 here). Within Cyprus itself, pharmaceuticals is the 17th largest of the 33 procurement categories tracked here.
Where do the Cyprus pharmaceuticals records on this page come from?
These 49 records are collected from 1 official source: TED (49). GlobalGov is an independent aggregator and is not affiliated with any of them; each record links back to the notice on its issuing portal. The set is rebuilt nightly, and the counts on this page were taken on 2026-11-22.
Most recent Pharmaceuticals tenders in Cyprus
None of these are open for bids now — they are the most recent records GlobalGov holds for this market, kept here so the shape of a typical pharmaceuticals notice in Cyprus is visible. Set an alert to be told when the next one opens.
Cyprus – Chemical reagents – Tender for the purchase of equipment and reagents for performing analyses using ELISA methodology, for the needs of the Immunology laboratory of the Nicosia General Hospital
Cyprus – Medicinal products for the blood and blood-forming organs – Προσφορά για την προμήθεια Enoxaparin ΦΥΥ 20/2026 ΟΚΥπΥ
Cyprus – Endocrine therapy medicinal products – Tender for the supply of Endocrine Gland Disease Medicines - No. Diag. 12/2026 - OAY
Cyprus – Laboratory reagents – Διαγωνισμός για Προμήθεια αναλωσίμων με την παροχή συνοδού εξοπλισμού για τον Μοριακό Έλεγχο του Αίματος με τη μέθοδο ΝΑΤ, για τις ανάγκες του Κέντρου Αίματος Σ.Υ.2/25
Cyprus – Counselling services – Παροχή Συμβουλευτικών Υπηρεσιών για την Ανάπτυξη και Εφαρμογή Ηλεκτρονικού Συστήματος, Προγραμματισμού Επιχειρησιακών Πόρων, Τύπου ERP στη ΡΑΕΚ
Cyprus-Nicosia: Medical gases
Other procurement categories in Cyprus
Pharmaceuticals procurement in other markets
Never Miss a Cyprus Government Contract
Finding Cyprus tenders usually means a local portal, a local registration and someone who reads the language. Get an alert you can read when a new pharmaceuticals opportunity is published there.
Start Free Trial